Legal & Regulatory Services

Angeion Group Acquires MedQuest Ltd

Angeion Group secures MedQuest legal services firm.

Angeion Group, a leading provider of legal notice and administration services, today announced the acquisition of MedQuest Ltd (“MedQuest”), a trusted legal services firm supporting personal injury and medical malpractice litigation.

Founded in 1983, MedQuest supports personal injury and medical malpractice matters by producing litigation-ready work products, including life care plans, future medical cost projections, and detailed medical record reviews and chronologies. MedQuest also connects firms with board-certified medical and billing experts for specialty review and testimony support. The company serves both plaintiff and defense firms, with outputs designed to be consistent, well-documented, and defensible in litigation settings.

“MedQuest has earned trust by delivering consistent, defensible work product and a dependable network of board-certified experts,” said Dan Miner, President of Mass Torts and Single Event at Angeion Group. “This acquisition expands our ability to support single-event personal injury matters with life care planning and future medical cost analysis so firms can evaluate exposure and damages with greater speed and confidence.”

“We’re incredibly proud of the trust we’ve earned from both defense and plaintiff firms over the past four decades,” said Elliot Stone, founder of MedQuest. “Joining Angeion enables us to maintain the quality our clients expect while gaining additional resources to further advance MedQuest’s mission.”

The acquisition bolsters Angeion Group’s existing single-event practice by expanding its service offerings to include medical cost projections, life care planning, and medical expert review.

MedQuest is the fourth acquisition under the Angeion platform since the 2024 majority investment from Renovus Capital Partners.

Discover the latest trends and insights—explore the Business Insights Journal for up-to-date strategies and industry breakthroughs!

Related posts

FLGT Investors Invited to Join Fulgent Genetics Fraud Probe

Business Wire

CIVI INVESTOR ALERT: Lead Class Action Lawsuit for Civitas Losses

PR Newswire

Centene (CNC) Fraud Probe: Investors Urged to Contact Glancy Prongay

Business Wire